The board of Cyclopharm Limited announced the appointment of Mr. Kevin Barrow as a Non Executive director, with the appointment effective today. Mr. Barrow brings to the Cyclopharm board more than 20 years of experience in the healthcare industry, which includes numerous governance and senior executive roles. Mr. Barrow is currently Chief Executive Officer of the Butterfly Foundation, Australia's national charity providing clinical services and support to address eating disorders and body image issues.

Prior to this role, Mr. Barrow was the Managing Director at Philips Australia and New Zealand overseeing all Philips' operations in the region, while also direct General Manager for the Healthcare division, a leader in cardiac care, acute care and home healthcare. Mr. Barrow joined Philips from BD, (Becton, Dickinson and Company), a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. Mr. Barrow was the Managing Director for BD Australia and New Zealand a market leader in the Medical, Diagnostic and Lifescience sector.

Prior to this, Mr. Barrow held several senior sales and marketing management roles at pharmaceutical company Eli Lilly. Mr. Barrow is a nonexecutive director of Wandi Nerida, Australia's first residential recovery centre for people affected by an eating disorder and was previously Chair of the Medical Technology Association of Australia (MTAA), where he was a director between 2009 and 2014. Mr. Barrow was born in New Zealand and holds a Master of Science (with 1st Class Honours) from the Waikato University, New Zealand.

He obtained an MBA from the Macquarie Graduate School of Management, Sydney, Australia and is a graduate of the Australian Institute of Company Directors.